dm+d
354038002
Medicine Compliance Aid Stability
Zaditen
Alfasigma S.p.A.
Alfasigma S.p.A.
Zaditen
Tablet 1mg
A2 · Amber 2 No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage
18 October 2022
Lactation Safety Information
Oral
Oral
Cetirizine/Loratadine. If a sedating antihistamine required chlorphenamine is preferred (see summary
Sedating antihistamine
No published evidence of safety
Long half-life increases risk of accumulation in breastfed infants
Monitor infant for drowsiness
18 September 2020
For use in the eye
For use in the eye
No published evidence for use in breastfeeding
Limited systemic absorption in the mother, therefore negligible risk to the infant
18 September 2020